AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02599103 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tallow
Description: participants drinks the milk shakes prepared from 60g of tallow
Study NCT02599103 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fried tallow
Description: participants drinks the milk shakes prepared from 60g of fried tallow
Study NCT02291432 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: autologous muscle-derived cells (AMDC)
Description: Cell treatment
Study NCT04464616 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: spinal anaesthesia
Description: spinal anaesthesia will be performed with the patient in sitting position at the L3-L4 or L4-L5 interspaces with a 25 or 27 G spinal tip needle with the study drug in the total volume of 3 ml.
Study NCT04464616 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: spinal anaesthesia
Description: spinal anaesthesia will be performed with the patient in sitting position at the L3-L4 or L4-L5 interspaces with a 25 or 27 G spinal tip needle with the study drug in the total volume of 3 ml.
Study NCT01736774 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care intervention
Description: The usual care intervention will include appropriate primary care as required including medication
Study NCT01736774 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy treatment
Description: Exercise and manipulative therapy treatment for 10 weeks:The treatment intervention consists of two visits per week for the first four weeks (8 treatments) and one visit per week for the last six weeks (6 treatments)
Study NCT01041846 — intervention group
Intervention type: DRUG
Intervention: No intervention
Description: This is an observational study. Patients receiving 20 mg/m2 of decitabine injection intravenously (into a vein) once daily for 5 days every 4 weeks will be observed.
Study NCT02194712 — intervention group
Intervention type: OTHER
Intervention: Urine CAA detection
Description: In addition to routine diagnostics, serum and urine samples are stored for retrospective UCP-CAA antigen determination.
Study NCT01307137 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer-led intervention
Description: An expert patient in the peer-led intervention will provide effective support for patients and families to accelerate adoption of CER for diabetes prevention and management in the elderly. This will lead to better self-efficacy and clinical outcomes.~Those veterans enrolled in the MOVE! and HARC programs that have showed success in management of weight and Diabetes will be offered to become peer-leaders.~* Weight management success is defined as a loss of at least 5% of the weight since enrollment~* Diabetes management will be defined as adequate control of HbA1c and/ or blood pressure and lipids.~The potentials peer-leaders will have a pre-assessment test to evaluate diabetes prevention and management knowledge and motivation and support skills.
Study NCT01307137 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth Intervention
Description: Participants in the TAP group will receive mobile phones that will be programmed to monitor specific clinical parameters and promote adoption of CER on prevention and management of diabetes, with protocols developed in part based on the input from the focus groups. These devices display messages, tips, reminders and questions regarding healthy lifestyle and clinical parameters of diabetes, which will be developed using best practice guidelines. Participants will be asked to respond to the questions daily if they can. Also they are asked to provide their daily weight, blood pressure, and glucose levels (the later only for patients with diabetes).
Study NCT03799692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Drug: Nanoparticle Albumin-Bound Paclitaxel Nanoparticle Albumin-Bound Paclitaxel 125mg/m2, iv, d1, 8, 15.~Drug: Carboplatin AUC=2 iv, d1, 8, 15.
Study NCT01880086 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Study NCT01880086 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo pill that will have appearance identical to the treatment pill but will not contain active medication.
Study NCT02419612 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saxagliptin
Study NCT02419612 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Study NCT02419612 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glimepiride
Study NCT02419612 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT02849860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IDP-121 Lotion
Description: Lotion
Study NCT03241628 — intervention group
Intervention type: DEVICE
Intervention: Dressing Glove
Description: Viscose dressing glove
Study NCT00581347 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: outreach services
Description: Tracking/reminder/recall/home visit strategy.
Study NCT00514644 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carotid ultrasound examination
Description: Ultrasonographic examination of the carotid arteries to determine the grade of carotid stenosis.
Study NCT00514644 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Panorama examination
Description: Examination with the odontological radiological method Panorama, including a frontal verification image
Study NCT01707355 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: intervention - poster
Study NCT01665885 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ZOLL Thermogard XP
Description: Induction of hypothermia with 1L cold crystalloid infusions (0,9%NaCl or Ringer's solution). Cooling catheter placement at the earliest 30min after end of thrombolysis.
Study NCT01665885 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BARD/Medivance Arctic Sun 5000
Description: Induction of hypothermia with 1L cold crystalloid infusions (0,9%NaCl or Ringer's solution) and simultaneous start of surface cooling.
Study NCT04274244 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML
Description: Regenerative periodontal therapy + Cross-linked hyaluronic acid 1.8%:~* The modified minimal invasive surgical technique, described by Cortellini 2011, will be used to raise the interdental papilla over the bone defect.~* Measurement of bone defect with a 0.5mm periodontal probe (PCP-UNC 15, Hu-Friedy Manufacturing, Illinois, USA) to characterize the defect anatomy.~* Inflammatory tissue will be debrided and the root carefully planed using Gracey curettes.~* The site will be washed with physiologic sterile solution, dried and the root wil be conditioned with 24% Ethylenediamine tetraacetic acid (EDTA) for two minutes, then the defect area will be carefully rinsed with sterile saline to remove any residual EDTA.~* Application of Hyadent BG® 1,8% filling the bone defect from the bottom upwards in the test group.~* Single internal modified mattress suture (5/0 Vicryl, Ethicon).~* Sutures will be removed after two weeks.
Study NCT04274244 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enamel Matrix Proteins (Active comparator group)
Description: Regenerative periodontal therapy + Enamel matrix proteins:~* The modified minimal invasive surgical technique, described by Cortellini 2011, will be used to raise the interdental papilla over the bone defect.~* Measurement of bone defect with a 0.5mm periodontal probe (PCP-UNC 15, Hu-Friedy Manufacturing, Illinois, USA) to characterize the defect anatomy.~* Inflammatory tissue will be debrided and the root carefully planed using Gracey curettes.~* The site will be washed with physiologic sterile solution, dried and the root wil be conditioned with 24% Ethylenediamine tetraacetic acid (EDTA) for two minutes, then the defect area will be carefully rinsed with sterile saline to remove any residual EDTA.~* Application of Emdogain® filling the bone defect from the bottom upwards in the active comparator group.~* Single internal modified mattress suture (5/0 Vicryl, Ethicon).~* Sutures will be removed after two weeks.
Study NCT01959763 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weight loss counseling program
Description: Randomized study persons are given either one of the two different methods of weight loss counseling program without ICT or with ICT-based counseling. As a control for the study groups one group is receiving only ICT-based counseling and one group does not receive any of the counseling methods.
Study NCT02594904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yinzhihuang Oral Liquid
Description: All the four groups will be given same treatment as being described in arm description.
Study NCT00676312 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTH134
Study NCT03374592 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Volumetric Intensity-Modulated Arc Therapy
Description: Advanced radiotherapy technique
Study NCT03374592 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Radiotherapy
Description: Conventional radiotherapy technique
Study NCT02721810 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Consideration of 3-month functional prognosis
Study NCT04548115 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ARTISAN Condition
Description: Youth and senior participants will be randomly paired and engage in the 5-weekly, 3-hour ARTISAN intervention as dyads (totaling 15 hours of intervention). In the first four weeks of the ARTISAN, dyads will engage in themed museum tours facilitated by a docent (45min), guided storytelling (45 min) and professionally-led art-making (45 min). The remaining time (45 min) is allocated for session breaks, session introduction/closing, and buffer time for movement around the gallery. The final week involves an exhibition where participants share their artworks with the public and reflect on their experiences and artworks. The weekly session themes are as follows: Week 1: Discovering our National Heritage (Art medium: Clay); Week 2: Strengthening Social Bonds (Art medium: Acrylic Paints); Week 3: Overcoming Adversities and Resilience (Art medium: Beads); Week 4: Building Dreams and Aspirations (Art medium: Recycled Materials); Week 5: Sharing our Stories and Legacies (Community Showcase)
Study NCT04548115 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intergenerational Participatory Arts Condition
Description: Youths and senior participants in this condition will be randomly paired and engage in a 5-weekly 45-minute group-based art activity conducted in a community space with 15 minutes of preparation/break time (totaling 5 hours of intervention). A professional artist or art therapist will facilitate art-making sessions with the participants in a community space, utilizing the same mediums that were used in ARTISAN. The weekly session themes are as follows: Week 1: Discovering our National Heritage (Art medium: Clay); Week 2: Strengthening Social Bonds (Art medium: Acrylic Paints); Week 3: Overcoming Adversities and Resilience (Art medium: Beads); Week 4: Building Dreams and Aspirations (Art medium: Recycled Materials); Week 5: Sharing our Stories and Legacies (Community Showcase)
Study NCT04548115 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intergenerational Art-space Condition
Description: Youths and senior participants in this condition will engage in a 5-weekly 45-minute group-based curated museum tour that follow the ARTISAN themes with 15 minutes of preparation/break time, and conducted by a trained docent at the National Museum Singapore (totaling 5 hours of intervention).The weekly session themes are as follows: Week 1: Discovering our National Heritage; Week 2: Strengthening Social Bonds; Week 3: Overcoming Adversities and Resilience; Week 4: Building Dreams and Aspirations; Week 5: Sharing our Stories and Legacies.
Study NCT04548115 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intergenerational Storytelling Condition
Description: Youths and senior participants in this condition will be paired to engage in a 5-weekly 45 minute group-based storytelling activity conducted in a community space with 15 minutes of preparation/break time (totaling 5 hours of intervention). Storytelling sessions will be conducted by a trained facilitator, and conversation starters from ARTISAN intervention will be used. The weekly session themes are as follows: Week 1: Discovering our National Heritage; Week 2: Strengthening Social Bonds; Week 3: Overcoming Adversities and Resilience; Week 4: Building Dreams and Aspirations; Week 5: Sharing our Stories and Legacies.
Study NCT00790920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desmoteplase
Description: 90 μg/kg bodyweight, IV, single bolus over 1 - 2 minutes on 1st day
Study NCT00790920 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IV, single bolus over 1 - 2 minutes on 1st day
Study NCT02478021 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Description: Effects of hydrocortisone compared to placebo on cognition
Study NCT02478021 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Hydrocortisone
Description: Effects of hydrocortisone compared to placebo on cognition
Study NCT02732613 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway
Description: If there were any conflicts of the Laryngeal Mask Airway classic size selection in slim patients by the actual or ideal body weight, size selection will based on actual body weight in Actual weight Group while ideal body weight in Ideal weight Group.
Study NCT02560935 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxyurea (Moderate Dose)
Description: The study intervention will include moderate dose hydroxyurea therapy at 20 mg/kg/day (range 17.5 - 26 mg/kg/day) for 36 months.
Study NCT02560935 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxyurea (Low Dose)
Description: The study intervention will include random allocation to low dose hydroxyurea therapy at 10 mg/kg/day (range 7 - 15 mg/kg/day) for 36 months.
Study NCT02601898 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lipoic acid
Description: Vaginal capsules (medical device) containing 10 mg of lipoic acid (1 per day)
Study NCT02601898 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Progesterone
Description: Vaginal capsules (drug) containing 200 mg of progesterone (2 per day)
Study NCT00793221 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Implantation of sirolimus-eluting coronary stent
Description: Implantation of sirolimus-eluting coronary stent after dilatation of the coronary occlusion
Study NCT00793221 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implantation of everolimus-eluting coronary stent
Description: Implantation of everolimus-eluting coronary stent after dilatation of the coronary occlusion
Study NCT02748694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-041
Description: TAK-041 tablets or oral suspension.
Study NCT04548115 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control Condition
Description: Participants in this condition will engage in a 5-weekly 45 minute group-based physical activity session conducted in the community with 15 minutes of preparation/break time (totaling 5 hours of intervention). Physical activity was selected over basic psychosocial care to test the effects of inter-generational contact independent of arts and heritage-based engagements.
Study NCT00231114 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Alair System
Description: Treatment of airways with the Alair System
Study NCT00231114 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Alair System
Description: Sham treatment of airways with the Alair System
Study NCT02748694 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TAK-041
Description: TAK-041 tablets or oral suspension.
Study NCT02748694 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TAK-041 Placebo
Description: TAK-041 placebo-matching suspension or tablet.
Study NCT00802555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARQ 197
Description: 360 mg administered twice daily until disease progression, unacceptable toxicity, or other discontinuation criterion is met
Study NCT02784470 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: gastroduodenal stent placement
Study NCT02784470 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: gastrojejunostomy
Study NCT00888901 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: eltrombopag
Description: eltrombopag tablets daily, in increasing dosage, for three months
Study NCT00888901 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: corticosteroids (Aprednislon)
Description: corticosteroids in decreasing dosage
Study NCT01554865 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Optifast
Description: 1-2 sachets of Optifast daily as part of diet modification (partial meal replacement diet)
Study NCT01562535 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pronation
Description: In this technique the arm is flexed 90 degrees and a gentle pronation is applied to the arm; then the arm is further flexed to 45 degrees until the clinician feels a click in the elbow meaning the re-accommodation of the radial head has been accomplished.
Study NCT01562535 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Supination
Description: The affected arm is in a 90 degrees flexion. The clinician will hold the arm by the elbow and then makes a gentle supination of the affected arm and flexion of the elbow until feeling the click and the child is able to move the arm without pain.
Study NCT04492150 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextrose 5%/Nacl 0.3% Inj_#3
Description: 250 mL/hour of dextrose 5% intravenous drip
Study NCT04492150 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Saline
Description: 250 mL/hour of normal saline intravenous drip
Study NCT04492150 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline
Description: 250 mL/hour of normal saline intravenous drip
Study NCT03657459 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Danger Signs of Heart Failure Videos
Description: Short (under 3 minutes each) videos on (a) recognition of dyspnea, fatigue and edema and (b) self-management of each (based on diet, fluid management and activities)
Study NCT01554865 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional diet counseling
Study NCT03677336 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dydrogesterone Oral Tablet
Description: Tablet, oral, 10 mg, 3 times daily, starting on the day of oocyte retrieval in the morning and during 8 days
Study NCT03677336 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Micronized progesterone
Description: Capsule, vaginal, 200 mg, 3 times daily, starting on the day of oocyte retrieval in the morning and during 8 days
Study NCT03677336 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo Dydrogesterone oral tablet
Description: Tablet, indistinguishable from dydrogesterone oral tablet
Study NCT03677336 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo Micronized progesterone
Description: Capsule, indistinguishable from micronized vaginal progesterone capsules
Study NCT01872637 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive Multi-Component Intervention
Study NCT01872637 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Study NCT00675155 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Far Infrared Radiation
Description: Radiation: Far Infrared Radiation (5μm to 20μm wavelength) Far Infrared radiation for 30 to 40 minutes per treatment session.
Study NCT02379559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: For the first 12-weeks, participants will come to our community based research office for up to 50 min/session, 3-days/week of supervised exercise. Exercise duration will increase from 75 min/wk at week 1 to 150 min/wk by week 4. Thereafter, men will maintain 150 min/wk of moderate-intensity physical activity.
Study NCT02379559 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention Control
Description: We will provide weekly healthy lifestyle tips via text messages, and will include tips such as managing stressors in life and getting better sleep.
Study NCT03607825 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurapheresis System
Description: CSF filtration system and lumbar catheter
Study NCT03311425 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolone
Description: Application of 40mg Depomedrol (methylprednisolone acetate) suspension into the retropharyngeal space prior to incision closure
Study NCT03311425 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dexamethasone
Description: Administration of 10mg Dexamethasone IV intraoperatively
Study NCT03311425 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Administration of 10mg Dexamethasone IV intraoperatively
Study NCT00885963 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sapacitabine
Description: twice daily by mouth for 7 days or once daily by mouth for 5 days/week x 2 weeks every 21 days
Study NCT03542097 — intervention group
Intervention type: OTHER
Intervention: MGMT methylation evaluation
Description: The MGMT methylation will be evaluated by extracting DNA from fresh and Formalin Fixed paraffin Embedded (FFPE) tumor samples
Study NCT02352363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CVT-301
Study NCT02352363 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Observational cohort